COVID-19 and Diabetes, Post-COVID Diabete

COVID-19 can exacerbate diabetes symptoms and increase the risk of severe outcomes. Post-COVID diabetes, a potential complication, may arise due to viral impact on pancreatic cells. Monitoring blood sugar levels, vaccination, and post-recovery diabetes screening are crucial to manage the interplay between COVID-19 and diabetes effectively.

    Related Conference of COVID-19 and Diabetes, Post-COVID Diabete

    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    June 25-26, 2026

    6th European Endocrinology and Diabetes Congress

    London, UK
    June 25-26, 2026

    5th International Summit on Hormonal Disorders

    London, UK
    July 20-21, 2026

    6th World Congress on Endocrine and Diabetes

    Paris, France
    July 23-24, 2026

    28th World Congress on Diabetes and Endocrine Disorders

    Paris, France
    August 17-18, 2026

    6th International Conference on Endocrinology and Diabetes

    Toronto, Canada
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    August 20-21, 2026

    6th Annual Summit on Diabetes and Endocrinology

    Paris, France
    September 23-24, 2026

    24th Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Paris, France
    September 28-29, 2026

    25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Berlin, Germany
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France
    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    November 23-24, 2026

    35th International Conference on Clinical Diabetes, Diabetic Medication & Treatment

    Amsterdam, Netherlands
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands